Critical considerations for targeting colorectal liver metastases with nanotechnology. (2020)
Attributed to:
Centre for Drug Safety Science (CDSS)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/wnan.1588
PubMed Identifier: 31566913
Publication URI: http://europepmc.org/abstract/MED/31566913
Type: Journal Article/Review
Volume: 12
Parent Publication: Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology
Issue: 2
ISSN: 1939-0041